Women with problem transvaginal mesh surgery must hurry to file claims

Women with problem transvaginal mesh surgery must hurry to file their claims, according to a major public information website for mesh victims, or risk not participating in current billion-dollar court settlements. The advisory was issued today by www.meshadvice.com, a website operated by northeastern Pennsylvania national media group MAJORMEDIA. Early September will likely be the latest that victims can make claim, it was noted.

"The complications from mesh surgery have literally made many women's daily life a nightmare," stated a firm official, "and both the court system and the manufacturers have recognized the need for compensation."

Many women are not aware of the limited time period due to limited national advertising asking for victims by national law firms. Many of the attorneys involved in the litigation have identified large numbers of qualifying victims and believe there are only limited additional victims. For this reason, most national advertising for victims has been discontinued.

Money is typically paid to women who have had transvaginal mesh implants, and the implants have been recommended by the woman's doctor for repair, removal, or replacement due to failure or complications. Six-figure settlements are commonplace.

MeshAdvice.com works with possible claimants to obtain an experienced attorney that is familiar with the mesh litigation.They have assisted more than 100 transvaginal mesh victims across the United States.

Women who call in to MeshAdvice receive a complimentary booklet on the litigation process to allow them to better understand their claims and how the legal system will work with them to come to a final payout.

Women that have suffered complications from mesh surgery may call meshadvice.com at 800-647-7968 to talk to an attorney knowledgeable on mesh injury cases. Office hours are from 8am to 7pm, Monday to Friday.

 

Source:

MAJORMEDIA

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
PDX engraftment predicts high recurrence and poor survival in triple-negative breast cancer